Enliven Therapeutics, Inc. ELVN
Nasdaq · stock · Pharmaceutical Preparations · website · IPO 2020-03-12
Enliven Therapeutics, Inc. institutional holders
| Investor | Shares | Value | % of company |
|---|---|---|---|
| CITADEL ADVISORS LLC | 1,871,515 | $73.4M | 3.15% |
| BlackRock Finance, Inc. | 2,730,773 | $63.8M | 4.59% |
| MILLENNIUM MANAGEMENT LLC | 345,318 | $13.5M | 0.58% |
| D. E. Shaw & Co., Inc. | 193,531 | $7.6M | 0.33% |
| Point72 Asset Management, L.P. | 39,600 | $1.6M | 0.07% |
% of company = reported institutional shares ÷ shares outstanding. Based on the latest reports; not every holder reports every quarter.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.